VANDA PHARMACEUTICALS INC. (VNDA) Operating cash flow 2016–2025
VANDA PHARMACEUTICALS INC. (VNDA) annual operating cash flow history from SEC filings — net cash provided by operating activities each fiscal year.
-$109.4MFY2025 · since FY2016: -$8.1M → -$109.4M
| Fiscal year | Value | YoY |
|---|---|---|
| FY2025 | -$109.4M | -594.6% |
| FY2024 | -$15.8M | -223.1% |
| FY2023 | $12.8M | -60.0% |
| FY2022 | $32.0M | -50.2% |
| FY2021 | $64.2M | +24.0% |
| FY2020 | $51.8M | +12.7% |
| FY2019 | $45.9M | +53.2% |
| FY2018 | $30.0M | +1612.2% |
| FY2017 | -$2.0M | +75.5% |
| FY2016 | -$8.1M | — |
Source: SEC XBRL filings · For reference only · Not investment advice